Literature DB >> 21914788

FGF23: is it ready for prime time?

Katherine Wesseling-Perry1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21914788     DOI： 10.1373/clinchem.2011.172890

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  FGF23 concentrations measured using "intact" assays similar but not interchangeable.

Authors:  Manish D Sinha; Charles Turner; David J Goldsmith
Journal:  Int Urol Nephrol       Date:  2013-05-07       Impact factor: 2.370

Review 2.  Familial tumoral calcinosis: a valuable vehicle for discovery.

Authors:  Orson W Moe
Journal:  Nephrol Dial Transplant       Date:  2014-08-21       Impact factor: 5.992

3.  Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.

Authors:  Huimin Chen; Ying Cui; Changying Xing; Yogendranath Purrunsing; Xiaoming Zha; Chong Shen; Ming Zeng; Guang Yang; Xiangbao Yu; Lina Zhang; Yao Jiang; Zhixiang Shen; Haoyang Ma; Caixia Yin; Yunfei Li; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2018-10-25       Impact factor: 2.370

4.  Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer.

Authors:  Amir Ghorbanihaghjo; Hassan Argani; Zahra Golmohamadi; Nadereh Rashtchizadeh; Mehran Mesgari Abbasi; Nasrin Bargahi; Amir Mansour Vatankhah; Davoud Sanajou
Journal:  J Bone Metab       Date:  2018-08-31

5.  Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease-Mineral and bone disorder with all-cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study.

Authors:  Bala Waziri; Eustasius Musenge; Raquel Duarte; Caroline Dickens; Therese Dix-Peek; Vakhtang Rekhviashvili; Graham Paget; Saraladevi Naicker
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

Review 6.  Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.

Authors:  Ariadne Bosman; Andrea Palermo; Julien Vanderhulst; Suzanne M Jan De Beur; Seiji Fukumoto; Salvatore Minisola; Weibo Xia; Jean-Jacques Body; M Carola Zillikens
Journal:  Calcif Tissue Int       Date:  2022-07-20       Impact factor: 4.000

Review 7.  Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury.

Authors:  T T van Duijl; D Soonawala; J W de Fijter; L R Ruhaak; C M Cobbaert
Journal:  Clin Proteomics       Date:  2021-02-22       Impact factor: 3.988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.